You are here:

timothy grass pollen allergen (GRAZAX)

Advice

In the absence of a submission from the holder of the marketing authorisation:

timothy grass pollen allergen (GRAZAX®) is not recommended for use within NHS Scotland.

Indication under review: Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this extension to the indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: timothy grass pollen allergen (GRAZAX)
SMC Drug ID: 868/13
Manufacturer: ALK-Abello Ltd
Indication: Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.
BNF Category:
Sub Category: 3.4 Antihistamines hyposensitisation and allergic emergencies
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 8 April 2013

Back